Results 91 to 100 of about 7,940 (254)

Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives.

open access: yesJournal of Managed Care & Specialty Pharmacy
Demodex infestation is the cause of more than two-thirds of all cases of blepharitis in the United States. Although symptoms may include crustiness, redness, or itching of the eyelids, diagnosis can be accomplished through a simple examination of the ...
Michael R. Page
semanticscholar   +1 more source

The exposomal imprint on rosacea: More than skin deep

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 3, Page 387-403, March 2026.
Rosacea reflects systemic and environmental interactions, not just a skin disorder. Key factors include environmental triggers, genetic and microbiome influences, diagnostic gaps in skin of colour and social determinants. Advances in multi‐omics and exposome integration highlight pathways towards precision medicine, prevention and equitable, patient ...
Katerina Grafanaki   +3 more
wiley   +1 more source

The frequency of Demodex spp in depression patients [PDF]

open access: yes, 2014
Objective: Demodex spp., usually located on the human skin, including the face and eyelashes, is a mandatory ectoparasite. The aim of this study was to evaluate the prevalence and factors affecting Demodex spp. in patients with depression.
Mehmet Hanifi Kokacya   +7 more
core   +1 more source

Oral JAK Inhibitors as a Promising Therapeutic Strategy for Refractory Rosacea: A Systematic Review and Meta‐Analysis

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 3, March 2026.
ABSTRACT Background Rosacea is a chronic inflammatory dermatosis. While standard therapies exist, managing refractory subtypes remains a therapeutic challenge. Oral Janus kinase (JAK) inhibitors have emerged as potential alternatives, but systematic evidence is lacking. Aims To evaluate the efficacy and safety of oral JAK inhibitors for rosacea through
Yu Peng   +4 more
wiley   +1 more source

The Prevalence of Demodex spp. Infestation in Dermatological Patients in Northern Poland

open access: yesLife
The presence of Demodex spp. mites on the skin is a common phenomenon in the human population. In most people, it is an asymptomatic infestation, but in some patients, it can contribute to the occurrence of diseases such as demodicosis, rosacea, or ...
Katarzyna Rychlik   +5 more
semanticscholar   +1 more source

Prevalence of demodex folliculorum and demodex brevisin the eyelash follicles of healthy subjects [PDF]

open access: yes, 2012
Demodex folliculorum ve Demodex brevis sadece insanlarda parazitlenen akarlardır. Genellikle hastaların yüzünde yaygın olup, kaşlarda, kirpiklerde, meibomian bezlerde, hatta vücudun diğer bölgelerinde rastlanabilmektedir.
Atambay, Metin   +2 more
core   +1 more source

The Investigation of Prevalence of Demodex spp. in University Students: The Case of the Faculty of Health Sciences

open access: yesTürkiye Parazitoloji Dergisi, 2019
Objective:The aim of this study was to determine the prevalence of Demodex spp. in college students, mostly adolescent individuals.Methods:A questionnaire including questions about the risk factors of Demodex spp.
Sinem Naz Sevgen, Neriman Mor
doaj   +1 more source

Common Demodex spp. identified on the arm and abdominal region of patient monitored for widespread pruritus

open access: yesMedicine Science, 2019
Demodex mite is a compulsory human ecto-parasite situated in or near pilo-sebase units. Demodex folliculorum and Demodex brevis are two species found in humans.
Yasemin Kaya   +3 more
doaj   +1 more source

Metronidazole and Demodex folliculorum

open access: yesActa Dermato-Venereologica, 1981
In vitro survival of Demodex folliculorum was tested in the presence of various concentrations of metronidazole (Flagyl). Demodex was found to survive in concentrations of as much as 1 mg/ml. Thus, it seems unlikely that the effect of metronidazole on rosacea is attributable to its direct activity on the mite.
A, Persi, A, Rebora
openaire   +2 more sources

Comparison of the Effectiveness of Ivermectin 1% Cream and Ketoconazole 2% Cream in Treating Facial Seborrheic Dermatitis: A Double‐Blind, Randomized, Controlled Clinical Trial

open access: yesHealth Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background and Aims Seborrheic dermatitis (SD) is a common, chronic, and relapsing disease affecting the patients’ quality of life. Expanding the treatment armamentarium provides better care for patients. Topical ivermectin, an anti‐inflammatory and anti‐parasitic agent, is a potential treatment for SD.
Mozhdeh Sepaskhah   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy